136 related articles for article (PubMed ID: 26698256)
1. The activities of serum paraoxonase and arylesterase and lipid profile in acute myeloid leukemia: preliminary results.
Çebi A; Akgun E; Esen R; Demir H; Çifci A
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4590-4. PubMed ID: 26698256
[TBL] [Abstract][Full Text] [Related]
2. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
3. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women.
Kumru S; Aydin S; Gursu MF; Ozcan Z
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):177-81. PubMed ID: 15140512
[TBL] [Abstract][Full Text] [Related]
4. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.
Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O
Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774
[TBL] [Abstract][Full Text] [Related]
6. Decreased serum paraoxonase and arylesterase activities in patients with rosacea.
Takci Z; Bilgili SG; Karadag AS; Kucukoglu ME; Selek S; Aslan M
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):367-370. PubMed ID: 24854673
[TBL] [Abstract][Full Text] [Related]
7. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
8. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
10. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
[TBL] [Abstract][Full Text] [Related]
11. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies.
Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M
Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant status in blood of obese children: the relation between trace elements, paraoxonase, and arylesterase values.
Cayir Y; Cayir A; Turan MI; Kurt N; Kara M; Laloglu E; Ciftel M; Yildirim A
Biol Trace Elem Res; 2014 Aug; 160(2):155-60. PubMed ID: 24920129
[TBL] [Abstract][Full Text] [Related]
13. Assessment of paraoxonase activities in patients with knee osteoarthritis.
Soran N; Altindag O; Cakir H; Celik H; Demirkol A; Aksoy N
Redox Rep; 2008; 13(5):194-8. PubMed ID: 18796237
[TBL] [Abstract][Full Text] [Related]
14. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
15. Strawberries Added to the Usual Diet Suppress Fasting Plasma Paraoxonase Activity and Have a Weak Transient Decreasing Effect on Cholesterol Levels in Healthy Nonobese Subjects.
Zasowska-Nowak A; Nowak PJ; Bialasiewicz P; Prymont-Przyminska A; Zwolinska A; Sarniak A; Wlodarczyk A; Markowski J; Rutkowski KP; Nowak D
J Am Coll Nutr; 2016 Jul; 35(5):422-35. PubMed ID: 26934671
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
Kirbas A; Kirbas S; Cure MC; Tufekci A
J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
[TBL] [Abstract][Full Text] [Related]
19. Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study.
Meisinger C; Freuer D; Bub A; Linseisen J
Lipids Health Dis; 2021 Jul; 20(1):81. PubMed ID: 34332593
[TBL] [Abstract][Full Text] [Related]
20. The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender.
Ellidag HY; Eren E; Akdag M; Giray O; Kiraz K; Yilmaz N
Ukr Biochem J; 2016; 88(6):76-86. PubMed ID: 29236376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]